Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heat effects on drug delivery across human skin.
Hao J, Ghosh P, Li SK, Newman B, Kasting GB, Raney SG. Hao J, et al. Among authors: newman b. Expert Opin Drug Deliv. 2016;13(5):755-68. doi: 10.1517/17425247.2016.1136286. Epub 2016 Jan 25. Expert Opin Drug Deliv. 2016. PMID: 26808472 Free PMC article. Review.
Navigating sticky areas in transdermal product development.
Strasinger C, Raney SG, Tran DC, Ghosh P, Newman B, Bashaw ED, Ghosh T, Shukla CG. Strasinger C, et al. Among authors: newman b. J Control Release. 2016 Jul 10;233:1-9. doi: 10.1016/j.jconrel.2016.04.032. Epub 2016 Apr 24. J Control Release. 2016. PMID: 27117457 Review.
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective.
El-Gendy N, Bertha CM, Abd El-Shafy M, Gaglani DK, Babiskin A, Bielski E, Boc S, Dhapare S, Fang L, Feibus K, Kaviratna A, Li BV, Luke MC, Ma T, Newman B, Spagnola M, Walenga RL, Zhao L. El-Gendy N, et al. Among authors: newman b. Adv Drug Deliv Rev. 2022 Oct;189:114519. doi: 10.1016/j.addr.2022.114519. Epub 2022 Aug 28. Adv Drug Deliv Rev. 2022. PMID: 36038083 Review.
Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective.
Newman B, Babiskin A, Bielski E, Boc S, Dhapare S, Fang L, Feibus K, Kaviratna A, Li BV, Luke MC, Ma T, Spagnola M, Walenga RL, Wang Z, Zhao L, El-Gendy N, Bertha CM, Abd El-Shafy M, Gaglani DK. Newman B, et al. Adv Drug Deliv Rev. 2022 Nov;190:114526. doi: 10.1016/j.addr.2022.114526. Epub 2022 Sep 5. Adv Drug Deliv Rev. 2022. PMID: 36067967 Review.
918 results